Barely Significant
← all excerpts

pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.

Oncotarget · 2016 · PMC4823061 · PMID 26544731

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

near-significantP = 0.1so close (0.05 < p ≤ 0.1)
The multivariate analysis using both significant and near-significant variables (up to P = 0.1 in the univariate analysis) showed that pERK + /pAkt − CTCs remained an independent factor associated with a good prognosis (hazard ratio = 9.389, P < 0.01).

also in 1,659 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.